Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Kowa discloses CSF-1R inhibitors

Oct. 23, 2020

New CDK inhibitors presented by Aurigene Discovery Technologies

Oct. 22, 2020

First patient enrolled in MERKLIN 2 trial of domatinostat plus avelumab in MCC

Oct. 22, 2020

Array BioPharma presents new PTPN11 inhibitors

Oct. 22, 2020

Storm Therapeutics patents METTL3 inhibitors

Oct. 22, 2020

FDA grants full approval to Venclexta combinations for newly diagnosed AML

Oct. 21, 2020

Cardiff Oncology reports phase II results with onvansertib in mCRPC

Oct. 21, 2020

AstraZeneca discloses new PROTACs for cancer therapy

Oct. 21, 2020

PDAC subtypes point to targeting strategies

Oct. 21, 2020

New substudy evaluates Treadwell's CFI-400945 in metastatic CRPC

Oct. 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...